Original Article
Quality of Life and Side Effects in Patients with Actinic Keratosis Treated With Ingenol Mebutate: A Pilot Study
Calidad de vida y efectos secundarios en los pacientes con queratosis actínica tratados con ingenol mebutato-estudio piloto
Leído
6697
Vecesse ha leído el artículo
3270
Total PDF
3427
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 21 | 13 | 34 |
| 2025 5 | 102 | 38 | 140 |
| 2025 4 | 94 | 34 | 128 |
| 2025 3 | 104 | 22 | 126 |
| 2025 2 | 97 | 41 | 138 |
| 2025 1 | 57 | 30 | 87 |
| 2024 12 | 62 | 41 | 103 |
| 2024 11 | 77 | 63 | 140 |
| 2024 10 | 40 | 45 | 85 |
| 2024 9 | 39 | 29 | 68 |
| 2024 8 | 73 | 49 | 122 |
| 2024 7 | 62 | 39 | 101 |
| 2024 6 | 74 | 43 | 117 |
| 2024 5 | 62 | 33 | 95 |
| 2024 4 | 69 | 53 | 122 |
| 2024 3 | 47 | 47 | 94 |
| 2024 2 | 44 | 37 | 81 |
| 2024 1 | 41 | 46 | 87 |
| 2023 12 | 35 | 55 | 90 |
| 2023 11 | 32 | 44 | 76 |
| 2023 10 | 34 | 45 | 79 |
| 2023 9 | 40 | 51 | 91 |
| 2023 8 | 29 | 24 | 53 |
| 2023 7 | 50 | 79 | 129 |
| 2023 6 | 46 | 56 | 102 |
| 2023 5 | 41 | 29 | 70 |
| 2023 4 | 39 | 26 | 65 |
| 2023 3 | 61 | 31 | 92 |
| 2023 2 | 57 | 21 | 78 |
| 2022 1 | 22 | 34 | 56 |
| 2022 12 | 64 | 39 | 103 |
| 2022 11 | 39 | 45 | 84 |
| 2022 10 | 80 | 43 | 123 |
| 2022 9 | 38 | 65 | 103 |
| 2022 8 | 42 | 41 | 83 |
| 2022 7 | 42 | 61 | 103 |
| 2022 6 | 41 | 47 | 88 |
| 2022 5 | 38 | 63 | 101 |
| 2022 4 | 37 | 70 | 107 |
| 2022 3 | 39 | 74 | 113 |
| 2022 2 | 33 | 53 | 86 |
| 2021 1 | 50 | 93 | 143 |
| 2021 12 | 33 | 54 | 87 |
| 2021 11 | 44 | 52 | 96 |
| 2021 10 | 51 | 65 | 116 |
| 2021 9 | 27 | 36 | 63 |
| 2021 8 | 36 | 39 | 75 |
| 2021 7 | 21 | 47 | 68 |
| 2021 6 | 43 | 38 | 81 |
| 2021 5 | 23 | 39 | 62 |
| 2021 4 | 46 | 79 | 125 |
| 2021 3 | 75 | 36 | 111 |
| 2021 2 | 69 | 37 | 106 |
| 2020 1 | 47 | 29 | 76 |
| 2020 12 | 42 | 20 | 62 |
| 2020 11 | 26 | 33 | 59 |
| 2020 10 | 39 | 25 | 64 |
| 2020 9 | 40 | 30 | 70 |
| 2020 8 | 34 | 38 | 72 |
| 2020 7 | 28 | 25 | 53 |
| 2020 6 | 47 | 59 | 106 |
| 2020 5 | 36 | 29 | 65 |
| 2020 4 | 44 | 31 | 75 |
| 2020 3 | 27 | 34 | 61 |
| 2020 2 | 5 | 10 | 15 |
| 2020 1 | 0 | 6 | 6 |
| 2019 12 | 2 | 16 | 18 |
| 2019 11 | 0 | 2 | 2 |
| 2019 10 | 0 | 5 | 5 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 0 | 2 | 2 |
| 2019 7 | 0 | 4 | 4 |
| 2019 6 | 2 | 18 | 20 |
| 2019 5 | 2 | 51 | 53 |
| 2019 4 | 0 | 6 | 6 |
| 2019 3 | 2 | 3 | 5 |
| 2019 2 | 2 | 0 | 2 |
| 2019 1 | 3 | 0 | 3 |
| 2018 12 | 6 | 3 | 9 |
| 2018 11 | 15 | 1 | 16 |
| 2018 10 | 17 | 3 | 20 |
| 2018 9 | 4 | 0 | 4 |
| 2018 7 | 0 | 2 | 2 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 0 | 7 | 7 |
| 2018 3 | 0 | 5 | 5 |
| 2018 2 | 29 | 6 | 35 |
| 2018 1 | 20 | 10 | 30 |
| 2017 12 | 47 | 13 | 60 |
| 2017 11 | 27 | 10 | 37 |
| 2017 10 | 24 | 5 | 29 |
| 2017 9 | 13 | 14 | 27 |
| 2017 8 | 6 | 8 | 14 |
| 2017 7 | 4 | 4 | 8 |
| 2017 6 | 13 | 28 | 41 |
| 2017 5 | 10 | 12 | 22 |
| 2017 4 | 8 | 25 | 33 |
| 2017 3 | 9 | 27 | 36 |
| 2017 2 | 7 | 12 | 19 |
| 2016 1 | 7 | 10 | 17 |
| 2016 12 | 15 | 24 | 39 |
| 2016 11 | 13 | 28 | 41 |
| 2016 10 | 13 | 25 | 38 |
| 2016 9 | 1 | 4 | 5 |
| 2016 7 | 9 | 0 | 9 |
| 2016 6 | 7 | 0 | 7 |
| 2016 5 | 7 | 13 | 20 |
| 2016 4 | 2 | 4 | 6 |
| 2016 2 | 0 | 21 | 21 |
| 2015 1 | 0 | 8 | 8 |
| 2015 11 | 0 | 20 | 20 |
| 2015 10 | 0 | 27 | 27 |
Mostrar todo
